The number of newly-diagnosed cancer patients that would 49 require radiotherapy treatment using an evidence-based approach 50 was estimated for all European countries for the year 2012 within use [1] . This evidence could be immediately applied to improve 66 cancer control planning with respect to placing the necessary 67 investments required to cope with the demand of cancer patients. 68 Long-term planning is required for radiotherapy facilities as 69 well as for the staff needed, due to the significant interval between that would need radiotherapy in the short-to medium-term time 74 horizon seems rational, and fits within the objectives of the 75 ESTRO-HERO project. 76 The aim of this paper is then to assess the number of new can-77 cer patients by tumor site that will require radiotherapy in 2025 as 78 compared to the 2012 data, using the national cancer incidence 79 estimates based on data from the population-based cancer reg-80 istries available in each European country together with projec-81 tions carried out by IARC in GLOBOCAN [6] . misleading exercise [14] .
256
The second source of data used in this study has been the OUP. of candidates for radiotherapy treatments [17] . In summary, a 273 decrease in the number of patients due to a reduction in indica-274 tions is highly improbable.
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The main result of this study is that the absolute number of new including the Russian Federation and Ukraine [19] . globally, the resources required to cope with the challenge posed 
